AVORO CAPITAL ADVISORS LLC 13D and 13G filings for Aadi Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-04 5:58 pm Purchase |
2025-02-28 | 13D | Aadi Bioscience, Inc. AADI |
AVORO CAPITAL ADVISORS LLC | 11,914,961 19.990% |
8,333,000 (+232.64%) |
Filing |
| 2024-12-23 3:51 pm Purchase |
2024-12-19 | 13D | Aadi Bioscience, Inc. AADI |
AVORO CAPITAL ADVISORS LLC | 3,581,961 14.500% |
110,209 (+3.17%) |
Filing |
| 2022-09-26 5:27 pm Purchase |
2022-09-22 | 13D | Aadi Bioscience, Inc. AADI |
AVORO CAPITAL ADVISORS LLC | 3,471,752 14.400% |
1,260,000 (+56.97%) |
Filing |
| 2021-08-30 5:27 pm Purchase |
2021-08-26 | 13D | Aadi Bioscience, Inc. AADI |
AVORO CAPITAL ADVISORS LLC | 2,211,752 10.700% |
2,211,752 (New Position) |
Filing |